EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Crossing subfamily borders: Mechanosensitive TREK‐1 and alkaline‐activated TASK‐4 form heterodimers with unique functional and pharmacological properties

Sven Schütte iD, Florian Schick iD, Emilia De Martino iD, Hannah Schmitz iD, Katharina E S Zander iD, Franziska Holz, Patrick Sauer iD, Luise Mildeberger iD, Moritz Linder iD, Axel Loewe iD, Aytug K Kiper iD, Silke Kauferstein iD und 3 weitere

British Journal of Pharmacology · 03.11.2026

DOI: 10.1111/bph.70698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 03.11.2026. Verfasst von Sven Schütte und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology and Pathophysiology, Vegetative Physiology, University of Marburg, Marburg, Germany. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Studienstiftung des deutschen Volkes, Medizinstiftung der Philipps-Universität Marburg.

AbstractSchlagwörterBibliografische AngabenZitieren

Abstract (Originalsprache)

Background and Purpose The tandem of two‐pore‐domain potassium (K 2P ) channels TREK‐1 and TASK‐4 are expressed in the heart and pancreatic beta‐cells. As TREK‐1 and TASK‐4 belong to distinct subfamilies with different functional hallmarks, heteromerization of these two channels was highly unexpected. However, due to their shared expression in these tissues and their involvement in congenital cardiac arrhythmias, the aim of this study was to probe for a possible formation of TREK‐1/TASK‐4 heterodimers. Experimental Approach Two‐electrode voltage‐clamp and inside‐out macropatch clamp recordings, together with immunohistochemistry and chemiluminescence‐based ELISA assays, were utilized to describe heteromerization of TREK‐1 and TASK‐4 channels and elucidate the characteristics of this heteromeric channel complex. Key Results Here, we show that the mechanosensitive TREK‐1 forms heteromeric channel complexes with the alkaline‐activated TASK‐4. The resulting heterodimers of these only remotely related channels have an enhanced temperature sensitivity, an altered pH dependence and regulation by extracellular sodium. Unlike TREK‐1, heteromeric TREK‐1/TASK‐4 channels are not inhibited via G s ‐coupled receptor activation, as the heterodimeric channels are not PKA sensitive. Strikingly, these novel heterodimeric channel complexes are characterized by a unique pharmacology. Conclusions and Implications The newly described heterodimerization across different K 2P channel families is of major relevance for drugs targeting TASK‐4 or TREK‐1. Their functional co‐expression in different tissues raises the possibility of developing drugs against cardiac arrhythmias and Type 2 diabetes by specifically targeting these unique heterodimeric channel complexes.

Schlagwörter

Stichwörter der Autor:innen

molecular pharmacologysignal transductionthe tandem of two‐pore‐domain potassium (K2P) channels

Autor:innen und Institutionen

  • Institute of Physiology and Pathophysiology, Vegetative Physiology, University of Marburg, Marburg, Germany.
  • Department of Legal Medicine, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Institute of Biomedical Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
  • Institute of Physiology, University Medicine Greifswald, Greifswald, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Rhein-Main, Frankfurt/Main, Germany.
  • Institute of Anatomy and Cell Biology, Medical Cell Biology, University of Marburg, Marburg, Germany.

ORCID-Profile: Sven Schütte, Florian Schick, Emilia De Martino, Hannah Schmitz, Katharina E S Zander, Patrick Sauer, Luise Mildeberger, Moritz Linder, Axel Loewe, Aytug K Kiper, Silke Kauferstein, Martin K-H Schäfer, Susanne Rinné, Niels Decher

Förderung

  • Deutsche Forschungsgemeinschaft
  • Studienstiftung des deutschen Volkes
  • Medizinstiftung der Philipps-Universität Marburg

Zitieren

APA

Schütte, S., Schick, F., De Martino, E., Schmitz, H., Zander, K. E. S., Holz, F., Sauer, P., Mildeberger, L., Linder, M., Loewe, A., Kiper, A. K., Kauferstein, S., Schäfer, M. K., Rinné, S., & Decher, N. (2026). Crossing subfamily borders: Mechanosensitive TREK‐1 and alkaline‐activated TASK‐4 form heterodimers with unique functional and pharmacological properties. British Journal of Pharmacology. https://doi.org/10.1111/bph.70698

Vancouver

Schütte S, Schick F, De Martino E, Schmitz H, Zander KES, Holz F, et al. Crossing subfamily borders: Mechanosensitive TREK‐1 and alkaline‐activated TASK‐4 form heterodimers with unique functional and pharmacological properties. British Journal of Pharmacology. 2026. doi:10.1111/bph.70698

BibTeX
@article{Schtte2026,
  author = {Schütte, Sven and Schick, Florian and De Martino, Emilia and Schmitz, Hannah and Zander, Katharina E S and Holz, Franziska and Sauer, Patrick and Mildeberger, Luise and Linder, Moritz and Loewe, Axel and Kiper, Aytug K and Kauferstein, Silke and Schäfer, Martin K-H and Rinné, Susanne and Decher, Niels},
  title = {Crossing subfamily borders: Mechanosensitive TREK‐1 and alkaline‐activated TASK‐4 form heterodimers with unique functional and pharmacological properties},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70698}
}
Kostenlos starten →